Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC023908.1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | HSD17B8 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | GBGT1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | SUPT7L | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | FIGNL1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | GRPEL2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | AC010287.1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | PTGIR | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | SPATA6L | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | PAX5 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |